Renaissance Technologies LLC Cuts Position in Retractable Technologies, Inc. (NYSE:RVP)

Renaissance Technologies LLC decreased its holdings in Retractable Technologies, Inc. (NYSE:RVP) by 5.1% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 340,759 shares of the company’s stock after selling 18,134 shares during the quarter. Renaissance Technologies LLC’s holdings in Retractable Technologies were worth $368,000 at the end of the most recent quarter.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.76 on Friday. Retractable Technologies, Inc. has a one year low of $0.71 and a one year high of $1.34. The company’s 50 day moving average price is $0.90 and its 200 day moving average price is $1.03. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The firm has a market capitalization of $22.72 million, a price-to-earnings ratio of -1.24 and a beta of 2.06.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. The firm had revenue of $6.03 million for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on shares of Retractable Technologies in a report on Thursday. They issued a “hold” rating on the stock.

Insider Activity

In other news, CEO Thomas J. Shaw acquired 71,422 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were bought at an average price of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders have bought 182,128 shares of company stock worth $166,565 over the last 90 days. Company insiders own 55.00% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.